24/7 Patient Assistance: 760-405-8205

Joseph Gibbons, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Joseph Gibbons is a medical oncologist from Cleveland,Ohio and he works at several hospitals in the area, such as University Hospitals Cleveland Medical Center.He did his Medical Schooling from The Ohio State University College of Medicine ,Internship  from Internal Medicine from St Luke's Hospital and Residency in Internal Medicine from Medical College of Ohio at Toledo. The doctor is certified in Medical Oncology , Internal Medicine & Hematology from American Board of Internal Medicine and has an experience of more than 20 years.



  • Education & Training

    dept_icon

    The Ohio State University College of Medicine

    Medical School

    dept_icon

    St Luke's Hospital

    Internship

    dept_icon

    University of Michigan Hospitals and Health Centers

    Residency

    dept_icon

    Medical College of Ohio at Toledo

    Residency

    dept_icon

    University of Alabama Medical Center

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Publications & Memberships

    Dr. Joseph Gibbons has contributed to 3 publications.

    Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.

    Chee CE, Krishnamurthi S, Nock CJ, Meropol NJ, Gibbons J, Fu P, Bokar J, Teston L, O'Brien T, Gudena V, Reese A, Bergman M, Saltzman J, Wright JJ, Dowlati A, Brell J; Oncologist. 2013-01-01.

    See more >>

    Phase I trial of pomalidomide given for patients with advanced solid tumors.

    Cooney MM Nock C Bokar J Krishnamurthi S Gibbons J Rodal MB Ness A Remick SC Dreicer R Dowlati A ; Cancer Chemother Pharmacol . 2012 Aug 9 .

    See more >>

    Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy.

    Annaberdyev S Gibbons J Hardacre JM ; World J Surg Oncol . 2009 .

    See more >>